Home › Free Stock Grades › CLPT
ClearPoint Neuro, Inc. (CLPT) Stock Grade
CLPT · Healthcare
C+
Market Cap
$387.4M
P/E Ratio
—
Revenue Growth (YoY)
+17.8%
Net Margin
-69.1%
Return on Equity
—
Dividend Yield
None
About ClearPoint Neuro, Inc.'s fundamentals
ClearPoint Neuro is a medical device company with a market capitalization of $387.4 million that has demonstrated solid revenue growth of 17.8% year-over-year, indicating expanding market adoption of its products. However, the company is not yet profitable, operating at a net margin of -69.1% and reporting a net loss in its latest annual statement, which is not uncommon for growth-stage medical device firms investing heavily in development and commercialization. The company does not currently pay a dividend, with cash being retained for operational and strategic purposes.